News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Says FDA To Take More Time To Review Label Wording for Acthar


9/9/2010 7:17:14 AM

Sept 8 (Reuters) - Questcor Pharmaceuticals Inc (QCOR.O) said U.S. health regulators extended, for the second time, review of the company's Acthar gel to treat seizures in infants.

Read at Reuters
Read at RTT News
Read at Forbes

comments powered by Disqus
Reuters
RTT News
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES